Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

         

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Angiogene Inc BioPharma

Angiogene Inc. is a private biotechnology company focused on the development of innovative drug-device combinations within the interventional cardiology and neurovascular fields, which aim to minimize invasive surgical procedures.
The Company is currently developing three major technology platforms for the treatment of cerebral aneurysms, restenosis and congestive heart failure.
Licensing-out:
-Radiolabelled DNA molecule (CVS, Oncology)
-Radiation detection catheter & imaging device (endovascular)
-Radioactive coated Stent (CVS, endovascular)
-Drug-eluting Stent (CVS, endovascular)


Activity:

- Licensing & Business Development
- Research & Development


Product / Technology type(s) covered:

- Devices
- Pharmaceuticals / Therapeutics


Therapeutic targets:

- Cardiovascular
- Neurology
- Oncology
- Radiology
- Stroke

Company Contact

Angiogene Inc
1851 Sherbrooke East, suite 704
H2K4L5 Montreal
PQ
Canada
Phone: 514-596-1111
FAX: 514-596-1119
Website: http://www.angiogene.com
Send an email

Markets Covered

a. HeadQuarter: Canada

b. Continent(s) active: North America , Europe

c. Countries active:


Corporate data:

Number of Employees: 30

Turnover:
Amount: Year: Currency:
- 2002 US Dollar

Year founded: 1996


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: 02-Apr-2003.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search